Cargando…
Progressive study of effects of erianin on anticancer activity
Erianin is the major bisbenzyl compound extracted from the traditional Chinese medicine Dendrohium chrysotoxum Lindl. Erianin possesses many biological properties relevant to cancer prevention and therapy. The previous studies confirmed that antitumor effects of erianin are regulated with multiple s...
Autores principales: | Zhang, Yuying, Zhang, Qianqian, Wei, Fanhua, Liu, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628150/ https://www.ncbi.nlm.nih.gov/pubmed/31371985 http://dx.doi.org/10.2147/OTT.S200161 |
Ejemplares similares
-
Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
por: Yan, Lili, et al.
Publicado: (2022) -
Erianin: A phytoestrogen with therapeutic potential
por: Li, Gangmin, et al.
Publicado: (2023) -
Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity
por: Zhang, Xinyong, et al.
Publicado: (2021) -
The roles of ERIANIN in tumor and innate immunity and its’ perspectives in immunotherapy
por: Yang, Zhen, et al.
Publicado: (2023) -
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2
por: Wang, Penglei, et al.
Publicado: (2023)